Stay updated on Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Sign up to get notified when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.

Latest updates to the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page
- Check4 days agoChange DetectedThe study's identifiers now include a reference to a 2018 U.S. NIH grant/contract, indicating NIH funding associated with this trial.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page's revision tag was updated from v3.6.4 to v3.6.5, signaling a newer version of the study details has been published.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page's revision tag was updated from v3.6.3 to v3.6.4, indicating a new build of the page.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page shows a new revision label 'Revision: v3.6.3', replacing the previous 'Revision: v3.6.0', indicating an updated page version. This update seems to be a routine template or system update rather than a change to study information.SummaryDifference0.0%

- Check76 days agoChange DetectedThe page now displays a recruitment status note ('No longer looking for participants') and adds new user-help sections (How to Read a Study Record, Common Questions, How to Join a Study), along with a formatting adjustment to the Intervention/Treatment heading and a Revision: v3.6.0 tag.SummaryDifference0.3%

- Check83 days agoChange DetectedThe page's revision label has been updated to v3.5.5, signaling a small software update to the site rather than changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Subcutaneous Nivolumab + rHuPH20 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Subcutaneous Nivolumab + rHuPH20 Clinical Trial page.